Research Article
Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study
Table 3
MC consumption characteristics during trial.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
†, 3 subjects failed to complete midtrial evaluation, 3 subjects terminated the trial prematurely. ‡. Abbreviations: MC: medical cannabis; THC: tetrahydrocannabinol; CBD: cannabidiol; SD: standard deviation. |